An IRB Member's Perspective on Access to Innovative Therapy
23 Pages Posted: 11 Mar 2010
Date Written: 1994
Abstract
Institutional Review Boards (IRBs) significantly influence patients’ access to innovative therapy. In hospitals, particularly academic medical centers, IRBs’ decisions may well control the extent to which certain types of innovative therapy are available. This article discusses the IRBs’ members individual responsibilities to facilitate research without sacrificing the interests of research subjects, whose protection is the primary responsibility of the IRB.
Keywords: IRBs, Innovative Therapy
Suggested Citation: Suggested Citation
Moore, Dale, An IRB Member's Perspective on Access to Innovative Therapy (1994). Albany Law Review, Vol. 57, p. 559, 1994, Available at SSRN: https://ssrn.com/abstract=1568154
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.